Cold & Cough Remedies (Pharmacies) - Lebanon

Revenue in the Cold & Cough Remedies market is projected to reach US$34.19m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.51%, resulting in a market volume of US$40.63m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$6.55 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in Lebanon has been experiencing steady growth in recent years.

Customer preferences: Lebanese consumers have shown a strong preference for over-the-counter cold and cough remedies purchased from pharmacies. This can be attributed to a combination of factors, including the convenience of purchasing these products from a trusted source, the availability of knowledgeable pharmacists to provide advice, and the perception that these products are of higher quality compared to those available in other retail channels.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Lebanon is the increasing demand for natural and herbal remedies. Lebanese consumers are becoming more health-conscious and are seeking products that are perceived to be more natural and less likely to cause side effects. This has led to a rise in the popularity of products containing ingredients such as honey, ginger, and herbal extracts. Another trend in the market is the growing demand for combination products. Lebanese consumers are looking for cold and cough remedies that offer multiple benefits, such as relieving congestion, soothing sore throats, and reducing coughing. Combination products that address these multiple symptoms in a single formulation are gaining popularity among consumers.

Local special circumstances: Lebanon has a high prevalence of cold and cough-related illnesses, particularly during the winter months. The country experiences cold and wet winters, which can contribute to the spread of respiratory infections. This creates a strong demand for cold and cough remedies, as Lebanese consumers seek relief from their symptoms. In addition, Lebanon has a well-developed healthcare system, with a large number of pharmacies spread across the country. This makes it easy for consumers to access cold and cough remedies, further driving the market growth.

Underlying macroeconomic factors: The growing Cold & Cough Remedies (Pharmacies) market in Lebanon can also be attributed to favorable macroeconomic factors. The country has a relatively high per capita income compared to other countries in the region, which allows consumers to spend more on healthcare products. Additionally, the government has been investing in the healthcare sector, which has led to improved access to healthcare services and increased awareness about the importance of managing cold and cough symptoms. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Lebanon is experiencing steady growth due to customer preferences for over-the-counter remedies purchased from pharmacies, the increasing demand for natural and herbal products, and the availability of combination products. The local special circumstances, such as the prevalence of cold and cough-related illnesses and the well-developed healthcare system, further contribute to the market growth. Favorable macroeconomic factors, including the high per capita income and government investments in the healthcare sector, also play a role in driving the market development.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.